Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain

Journal of Molecular Neuroscience

Volumn 39, Issue 3, 2009, Pages 380-390

  Takeda, Katsumichi ^a   Muramatsu, Mai ^b   Chikuma, Toshiyuki ^c   Kato, Takeshi ^d  

^a Abbott Diagnostic Division ^*  (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^d Bioelectro Analytical Science Ltd   (Japan)

Author keywords

Allodynia; Chronic constriction injury; Memantine; Microglia; Somatostatin; Substance P

Indexed keywords

CD11B ANTIGEN; MEMANTINE; NEUROPEPTIDE; SOMATOSTATIN; SUBSTANCE P;

ALLODYNIA; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME DEGRADATION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MECHANICAL ALLODYNIA; MICROGLIA; NERVE INJURY; NEUROPATHIC PAIN; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; RAT; SCIATIC NERVE INJURY;

ANALGESICS; ANIMALS; ANTIGENS, CD11; BRAIN; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; HYPERALGESIA; HYPOTHALAMUS; MALE; MEMANTINE; MICROGLIA; NEURALGIA; NEUROPEPTIDES; PERIAQUEDUCTAL GRAY; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; SCIATIC NEUROPATHY; SOMATOSTATIN; SUBSTANCE P;

RATTUS;

EID: 73849146529     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9224-5     Document Type: Article

References (56)

1. Ahmed, M. M., Hoshino, H., Chikuma, T., Yamada, M., & Kato, T. (2004). Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated Alzheimer's disease model. Neuroscience, 126, 639-649.
2. Alzate, O., Hussain, S. R., Goettl, V. M., et al. (2004). Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Molecular Brain Research, 128, 193-200.
3. Ambalavanar, R., Dessem, D., Moutanni, A., et al. (2006). Muscle inflammation induces a rapid increase in calcitonin gene-related peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior. Neuroscience, 143, 875-884.
4. Auld, D. S., & Robitaille, R. (2003). Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron, 40, 389-400.
5. Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33, 87-107.
6. Bianchi, M., Sotgui, M. L., Manfredi, B., & Sacerdote, P. (1996). Peripheral mononeuropathy affects hypothalamic and splenocyte beta-endorphin levels but not immune function in the rat. Brain Research Bulletin, 40, 269-272.
7. Brown, D. G., & Krupp, J. J. (2006). N-Methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics. Current Topics in Medicinal Chemistry, 6, 749-770.
8. Bucinskaite, V., Lundeberg, T., Stenfors, C., Belfrage, M., Hansson, P., & Theodorsson, E. (1995). Changes of neuropeptide concentrations in the brain following experimentally induced mononeuropathy in Wistar Kyoto and spontaneously hypertensive rats. Neuroscience Letters, 192, 93-96.
9. Carlton, S. M., & Hargett, G. L. (1995). Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neuroscience Letters, 198, 115-118.
10. Caruso, C., Durand, D., Watanobe, H., & Lasaga, M. (2006). NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence. Neuroscience Letters, 393, 60-64.
11. Coyle, D. E. (2007). Spinal cord transcriptional profile analysis reveals protein trafficking and RNA processing as prominent processes regulated by tactile allodynia. Neuroscience, 144, 144156.
12. Crack, P. J., Wu, T. J., Cummins, P. M., et al. (1999). The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane. Brain Research, 835, 113-124.
13. Dahms, P., & Mentlein, R. (1992). Purification of the main somatostatin-degrading protease from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. European Journal of Biochemistry, 208, 145-154.
14. Davidson, E. M., & Carlton, S. M. (1998). Intraplantar injection of dextrorphan, ketamine, or memantine attenuates formalininduced behaviors. Brain Research, 785, 136-142.
15. Dixon, W. J. (1980). Efficient analysis of experimental observations. Annual Review of Pharmacology and Toxicology, 20, 441-462.
16. Eisenberg, E., LaCross, S., & Strassman, A. M. (1995). The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mono-neuropathy. Neuroscience Letters, 187, 17-20.
17. Ferrari, D., Chiozzi, P., Falzoni, S., et al. (1997). Extracellular ATP triggers IL-1 release by activation the purinergic P2Z receptor of human macrophages. The Journal of Immunology, 159, 1451-1458.
18. Finnerup, N. B., & Jensen, T. S. (2004). Spinal cord injury painmechanisms and treatment. European Journal of Neurology, 11, 73-82.
19. Greenamyre, J. T. (1986). The role of glutamate in neurotransmission and in neurologic disease. Archives of Neurology, 43, 1058-1063.
20. Hains, B. C., Yucra, J. A., & Hulsebosch, C. E. (2001). Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. Journal of Neurotrauma, 18, 409-423.
21. Hains, B. C., Klein, J. P., Saab, C. Y., Craner, M. J., Black, J. A., & Waxman, S. G. (2003a). Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. The Journal of Neuroscience, 23, 8881-8892.
22. Hains, B. C., Willis, W. D., & Hulsebosch, C. E. (2003b). Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat. Experimental Brain Research, 149, 174-186.
23. Hartree, E. F. (1972). Determination of protein: a modification of the Lowry method that gives a linear photometric response. Analytical Biochemistry, 48, 422-427.
24. Helmchen, C., Fu, Q. G., & Sandkuhler, J. (1995). Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat. Neuroscience Letters, 187, 137-141.
25. Hua, X. Y., Chen, P., Marsala, M., & Yaksh, T. L. (1999). Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience, 89, 525-534.
26. Ji, R. R., Kohno, T., Moore, K. A., & Woolf, C. J. (2003). Central sensitization and LPT: Do pain and memory share similar mechanisms? Trends in Neurosciences, 26, 696-705.
27. Kato, T. (2004). Memantine: a therapeutic drug for Alzheimer's disease and the comparison with MK-801. Folia Pharmacologica Japonica, 124, 145-151.
28. Kato, T., Nakano, T., Kojima, K., Nagatsu, T., & Sakakibara, S. (1980). Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzymes. Journal of Neurochemistry, 35, 527-535.
29. Kreutzberg, G. W. (1996). Microglia: A sensor for pathological events in the CNS. Trends in Neurosciences, 19, 312-318.
30. Mantyh, P. W., & Hunt, S. P. (2004). Setting the tone: Superficial dorsal horn projection neurons regulate pain sensitivity. Trends in Neurosciences, 27, 582-584.
31. Medvedev, I. O., Malyshkin, A. A., Belozertseva, I. V., et al. (2004). Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neuropharmacology, 47, 175-183.
32. Milligan, E. D., Zapata, V., Chacur, M., et al. (2004). Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. European Journal of Neuroscience, 20, 2294-2302.
33. Minami, T., Okuda-Ashitaka, E., Hori, Y., et al. (1999). Involvement of primary afferent C-fibers in touch-evoked pain (allodynia) induced by prostaglandin E2. European Journal of Neuroscience, 11, 1849-1856.
34. Obata, H., Eisenach, J. C., Hussain, H., Bynum, T., & Vincler, M. (2006). Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. The Journal of Pain, 7, 816-822.
35. Onley, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., & Sesma, M. A. (1991). NMDA antagonist neurotoxicity: Mechanism and prevention. Science, 254, 1515-1518.
36. Panerai, A. E., Sacerdote, P., Brini, A., Bianchi, M., & Mantegazza, P. (1988). Central nervous system neuropeptides after peripheral nerve deafferentiation. Peptides, 9, 319-324.
37. Paxinos, G., & Watson, C. (1986). The rat brain in stereotaxic coordinates (2nd ed.). San Diego: Academic.
38. Petrenko, A. B., Yamakura, T., Baba, H., & Shimoji, K. (2003). The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesthesia & Analgesia, 97, 1108-1116.
39. Raghavendra, V., Tanga, F., & DeLeo, J. A. (2003a). Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. The Journal of Pharmacology and Experimental Therapeutics, 306, 624-630.
40. Raghavendra, V., Tanga, F., Rutkowski, M. D., & DeLeo, J. A. (2003b). Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain, 104, 655-664.
41. Restuccia, D., Di Lazzaro, V., Valeriani, M., Tonali, P., & Mauguiere, F. (1992). Segmental dysfunction of the cervical cord revealed by abnormalities of the spinal N13 potential in cervical spondylotic myelopathy. Neurology, 42, 1054-1063.
42. Rosen, A., Zhang, Y. X., Lund, I., Lundeberg, T., & Yu, L. C. (2004). Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration. Brain Research, 1001, 87-94.
43. Saito, T., Iwata, N., Tsubuki, S., et al. (2005). Somatostatin regulates brain amyloid peptide A42 through modulation of proteolytic degradation. Nature Medicine, 11, 434-439.
44. Samad, T. A., Moore, K. A., Sapirstein, A., et al. (2001). Interleukin1-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 410, 471-475.
45. Seltzer, Z., Dubner, R., & Shir, Y. (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain, 43, 205-218.
46. Sotgui, M. L. (1993). Descending influence on dorsal horn neuronal hyperactivity in a rat model of neuropathic pain. Neuroreport, 4, 21-24.
47. Svensson, C. I., Hua, X. Y., Protter, A. A., Powell, H. C., & Yaksh, T. L. (2003). Spinal p38 MAP kinase is necessary for NMDAinduced spinal PGE2 release and thermal hyperalgesia. Neuroreport, 14, 1153-1157.
48. Sweitzer, S. M., Colburn, R. W., Rutkowski, M., & DeLeo, J. A. (1999). Acute peripheral inflammation induces moderate glial activation and spinal IL-1 expression that correlates with pain behavior in the rat. Brain Research, 829, 209-221.
49. Takeda, K., Uchiumi, F., Takita, M., & Kato, T. (1989). A rapid enzyme immunoassay for cholecystokinin octapeptide sulfate. Neurochemistry International, 15, 55-60.
50. Tseng, S. H. (1998). Suppression of autotomy by N-methyl-Daspartate receptor antagonist (MK-801) in the rat. Neuroscience Letters, 240, 17-20.
51. Ueda, H., & Inoue, M. (2001). Animal models and peripheral nociception tests for the study of neuropathic pain. Folia Pharmacologica Japonica, 118, 89-95.
52. Wall, J. T., Xu, J., & Wang, X. (2002). Human brain plasticity: An emerging view of the multiple substrates and mechanisms that cause cortical changes and related sensory dysfunctions after injuries of sensory inputs from the body. Brain Research Reviews, 39, 181-215.
53. Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001). Glial activation: A driving force for pathological pain. Trends in Neurosciences, 24, 450-455.
54. Waxman, S. G., & Hains, B. C. (2006). Fire and phantoms after spinal cord injury: Na+ channels and central pain. Trends in Neurosciences, 29, 207-215.
55. Wilson, J. A., Garry, E. M., Anderson, H. A., et al. (2005). NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists. Pain, 117, 421-432.
56. Woolf, C. J., & Salter, M. W. (2000). Neuronal plasticity: Increasing the gain in pain. Science, 288, 1765-1768.